Wockhardt Ltd (WCKH)

Currency in INR
1,695.80
-1.05(-0.06%)
Delayed Data·
WCKH Scorecard
Full Analysis
Prominent player in the Pharmaceuticals industry
WCKH is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1,683.201,715.75
52 wk Range
835.151,870.00
Key Statistics
Bid/Ask
1,693.75 / 1,695.80
Prev. Close
1,696.85
Open
1,711.05
Day's Range
1,683.2-1,715.75
52 wk Range
835.15-1,870
Volume
12.5K
Average Volume (3m)
66.08K
1-Year Change
99.88%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
WCKH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
High return over the last year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Wockhardt Ltd Company Profile

Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical and biotech company, in India, the United States, the United Kingdom, Switzerland, Ireland, Russia, Europe, and internationally. It manufactures and trades pharmaceuticals, medicinal chemical, and botanical products, as well as chemicals and chemical products. The company also develops its flagship antibiotic, ZAYNICH zidebactam/cefepime, a novel beta lactam enhancer mechanism for the treatment of sepsis and hospital/ventilator associated pneumonia; FOVISCU, an antibiotic for gram-negative infections; MIQNAF nafithromycin, which targets azithromycin-resistant community respiratory pathogens; and ODRATE, a once-daily combination of ertapenem and zidebactam for resistant gram-negative infections through outpatient parenteral antimicrobial therapy. In addition, it develops and commercializes insulin analogs, glucagon-like peptide-1 agonists, and novel combination drug products; Biovac-B, a recombinant hepatitis-B vaccine; Wepox, a recombinant human erythropoietin; Wosulin, a recombinant human insulin; and Glaritus, a recombinant insulin glargine. Further, the company offers delivery devices for insulin, including Dispopen disposable pen and Mypen reusable pen. Wockhardt Limited was founded in 1967 and is headquartered in Mumbai, India.

Employees
2296
Market
India

Compare WCKH to Peers and Sector

Metrics to compare
WCKH
Peers
Sector
Relationship
P/E Ratio
−586.8x32.8x−0.5x
PEG Ratio
−6.480.870.00
Price/Book
6.4x5.4x2.6x
Price / LTM Sales
9.1x4.6x3.2x
Upside (Analyst Target)
-6.5%42.0%
Fair Value Upside
Unlock−4.3%6.6%Unlock

Earnings

Latest Release
May 29, 2025
EPS / Forecast
-1.57 / --
Revenue / Forecast
7.58B / --
EPS Revisions
Last 90 days

WCKH Income Statement

People Also Watch

388.40
BAJE
+0.04%
1,523.50
CENA
-1.05%
1,734.10
COFO
+0.79%
4,542.50
HIAE
+0.99%
2,462.10
BSEL
-1.01%

FAQ

What Stock Exchange Does Wockhardt Ltd Trade On?

Wockhardt Ltd is listed and trades on the Bombay Stock Exchange stock exchange.

What Is the Stock Symbol for Wockhardt Ltd?

The stock symbol for Wockhardt Ltd is "WCKH."

What Is the Wockhardt Ltd Market Cap?

As of today, Wockhardt Ltd market cap is 275.84B.

What Is Wockhardt Ltd's Earnings Per Share (TTM)?

The Wockhardt Ltd EPS (TTM) is -3.00.

From a Technical Analysis Perspective, Is WCKH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Wockhardt Ltd Stock Split?

Wockhardt Ltd has split 1 times.

How Many Employees Does Wockhardt Ltd Have?

Wockhardt Ltd has 2296 employees.

What is the current trading status of Wockhardt Ltd (WCKH)?

As of 30 Jul 2025, Wockhardt Ltd (WCKH) is trading at a price of 1,695.80, with a previous close of 1,696.85. The stock has fluctuated within a day range of 1,683.20 to 1,715.75, while its 52-week range spans from 835.15 to 1,870.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.